Success Metrics

Clinical Success Rate
100.0%

Based on 9 completed trials

Completion Rate
100%(9/9)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
1
8%
Ph phase_3
2
15%
Ph phase_2
2
15%
Ph phase_4
4
31%
Ph phase_1
1
8%

Phase Distribution

1

Early Stage

2

Mid Stage

6

Late Stage

Phase Distribution10 total trials
Phase 1Safety & dosage
1(10.0%)
Phase 2Efficacy & side effects
2(20.0%)
Phase 3Large-scale testing
2(20.0%)
Phase 4Post-market surveillance
4(40.0%)
N/ANon-phased studies
1(10.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

9 of 9 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

13

all time

Status Distribution
Completed(9)
Other(4)

Detailed Status

Completed9
unknown4

Development Timeline

Analytics

Development Status

Total Trials
13
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (10.0%)
Phase 22 (20.0%)
Phase 32 (20.0%)
Phase 44 (40.0%)
N/A1 (10.0%)

Trials by Status

completed969%
unknown431%

Recent Activity

Clinical Trials (13)

Showing 13 of 13 trials
NCT05560516Not Applicable

Qutenza Versus Duloxetine in Chemotherapy-induced Peripheral Neuropathy (CIPN)

Unknown
NCT01393795Phase 2

Qutenza®-Remodulin® in Pulmonary Arterial Hypertension Patients

Completed
NCT02822625Phase 3

Efficacity of a Standardized Hypnotic Message During the Application of a Qutenza (Capsaicin) 8% Patch

Completed
NCT03317613Phase 2

Clinical Trial Assessing the Efficacy of Capsaicin Patch (Qutenza®) in Cancer Patients With Neuropathic Pain

Completed
NCT03576508Phase 1

A Study to Compare Levels of Capsaicin After Intra-Articular Injection and Topical Application in Patients With Painful Knee Osteoarthritis

Completed
NCT01416116Phase 4

Method of Pre-treatment for Application of QUTENZA Capsaicin 8% Patch

Completed
NCT01713426Phase 4

A Study to Compare QUTENZA With Pregabalin for the Treatment of Peripheral Neuropathic Pain (PNP) After 8 Weeks of Treatment

Completed
NCT01252160Phase 4

Safety and Effectiveness of Repeated Administration of QUTENZA Patches for Treatment of Pain Caused by Nerve Damage

Completed
NCT01748422

Qutenza (Topical Capsaicin 8%) for Painful Arteriovenous Fistulae

Unknown
NCT02171182

A Study of Efficacy and Safety of Qutenza in Patients With Post-operative Peripheral Neuropathic Pain

Completed
NCT01478607Phase 3

A Study to Evaluate the Long-term Safety of Repeated QUTENZA Administration for Treatment of Pain Caused by Nerve Damage in Diabetic Patients

Completed
NCT01748435

Pre-emptive Analgesia With Qutenza in Lower Limb Amputation

Unknown
NCT01704339Phase 4

Qutenza for Critical Ischaemia in End Stage Renal Failure

Unknown

All 13 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
13